Maitreya Medicare Limited is a multispeciality hospital situated in Surat, Gujrat. The main focus of the hospital is multi-disciplinary integrated healthcare services, with primary secondary & tertiary care. Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.
IPO Review
| Parameter | Score (0-5) | Comments |
|---|---|---|
| Promotors/Sr. Management & Work Ethics | 4 | Doctors having 20+ yrs. exp in the promotor group, no open litigations or notices found in the RHP |
| Company Financials | 3 | Boost was seen in FY 21-22 due to Covid. However, the number seems to be settled down in H1 FY 23 |
| Segment Growth Opportunity | 4 | Headwinds for the hospital sector, but government schemes and sanctions do appear from time to time |
| Asking Valuation (compared with Peers) | 5 | ~10x asking PE. Peers in the range of 40-50x PE |
| Lead Manager’s past performance | 5 | Avg 53% listing day gain for last 16 IPOs |
| Consolidated Score | 4.3 |
Disclaimer – This is not an investment advice. Nobody has paid us anything for writing this review. This analysis is for education purposes only.
Leave a Reply